Adma Biologics (ADMA) Tax Provisions (2011 - 2026)

Adma Biologics (ADMA) has 4 years of Tax Provisions data on file, last reported at $12.2 million in Q4 2025.

• Quarterly Tax Provisions rose 180.61% year-over-year to $12.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $35.7 million (up 459.75% YoY) and the FY2025 annual result came in at $35.7 million, up 459.74% from the prior year.
• Tax Provisions improved to $12.2 million in Q4 2025, from $11.1 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $12.2 million in Q4 2025 to a low of -$15.2 million in Q4 2024.